Skip to main content


Podcast microphone headphones
Day 4: ACR 2019 Podcast
Podcast microphone headphones
Day 3: ACR 2019 Podcast
ACR Posters
ACR 2019 - Report from Day 3 (Tuesday)
Jack Cush, MD
Here's my summary of key studies presented Tuesday.  Tofacitinib in Polyarticular JIA Abstract L22. Dr. Hermine Brunner presented the results of a phase 3 trial of tofacitinib (Tofa) in children…
vasculitis open hand
Hepatitis C-related cryoglobulinemic vasculitis 
David Liew, MD
Flares of vasculitis can still be a problem after hepatitis C-related cryoglobulinemic vasculitis patients are cured of their hepatitis C by direct-acting antivirals, as demonstrated by data from…
vaccine shot
Herpes Zoster Vaccine Update
Cassandra Calabrese, DO
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older. Shingrix has replaced the…
needle haystack rare
Autoinflammatory Diseases at the ACR Annual Meeting
Jonathan Hausmann, MD
It has been a wonderful year for autoinflammatory diseases at the ACR Annual Meeting. I attended my first ACR Annual Meeting in 2011 in Chicago. In that meeting, there were 29 abstracts on…
light bulb thought
ACR 2019 - Report from Day One (Sunday)
Jack Cush, MD
Sunday was the first full day of scientific sessions at the 2019 ACR/ARP meeting in Atlanta. Yesterday we shared our initial news articles, videos and more with you. Following is my roundup of day…
A Focus on WOCBA (Women of Childbearing Age)
Maeve Gamble, MD
Many rheumatic diseases affect women of childbearing age. In the age of biologic therapy, women are achieving better disease activity and there are increasing numbers of women with rheumatic diseases…
I have been attending the ACR Review Course for more than a decade, and it seems every year it gets better and better. Contrary to what most people think, this is not a board review course; it is…
Arrow diverge
When Classification and Diagnosis Diverge
Michael Putman, MD
Like many rheumatologists who are headed to the 2019 American College of Rheumatology meeting in Atlanta, I am eagerly looking forward to learning about the new criteria in vasculitis, lupus, and…